Targeted axillary dissection

PROCEDURE3 trials

Sponsors

University Hospital Ostrava, Jewish General Hospital, Karolinska Institutet

Conditions

Axillary MetastasesBreast CancerBreast Cancer FemaleBreast CarcinomaBreast SurgeryEarly-stage Breast CancerLymph Node MetastasesSentinel Lymph Node

Unknown Phase

Ideal Marker for Targeted Axillary Dissection

CompletedNCT04580251

University Hospital OstravaBreast Cancer

Start: 2021-01-01End: 2023-05-30Updated: 2023-09-07

Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer

RecruitingNCT04671511

Jewish General HospitalBreast Cancer Female, Early-stage Breast Cancer, Lymph Node Metastases +2

Start: 2021-03-30End: 2026-07-31Target: 98Updated: 2025-02-20

Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer

RecruitingNCT06869629

Karolinska InstitutetBreast Carcinoma, Breast Cancer, Breast Surgery

Start: 2026-05-13End: 2041-12-31Target: 1380Updated: 2026-08-17

Related Papers

Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial.

2023-08-1913 citations